Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Transplantation of human Wharton’s jelly-derived mesenchymal stem cells highly expressing TGFβ receptors in a rabbit model of disc degeneration

Fig. 1

Variation in expression levels of TβRI/ALK5 and TβRII in WJ-MSCs among donors. FACS analysis showing differences in the expression levels of TβRI/ALK5 and TβRII in WJ-MSCs among donors a. MSC-highTR are defined as when more than 5.0 % and 20.0 % of cells express TβRI/ALK5 and TβRII, respectively, while MSC-lowTR are defined as when around 1.0 % and 7.0 % of cells express TβRI/ALK5 and TβRII, respectively. b Quantification of FACS analysis (n = 3). *p <0.05. ALK5 activin-like kinase receptor 5, MSC-highTR Wharton’s Jelly-derived mesenchymal stem cells highly expressing TβRI/ALK5 and TβRII, MSC-lowTR Wharton’s Jelly-derived mesenchymal stem cells lowly expressing TβRI/ALK5 and TβRII, TβR transforming growth factor-beta receptor

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512